FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ambrisentan Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Par Pharmaceutical (New 12/23/2021)

Company Contact Information:
800-828-9393, option 5 then option 2

Presentation Posting Date Related Information
5 mg (NDC 49884-353-11, 49884-353-62 ) 12/23/2021 After January or February 2022, product with less than 12 months shelf-life, will be only available for order
10 mg (NDC 49884-354-11, 49884-354-62) 12/23/2021 After January or February 2022, product with less than 12 months shelf-life, will be only available for order

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English